Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases

@inproceedings{Topta2014LevofloxacinFT,
  title={Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases},
  author={Tayfur Toptaş and Isik Kaygusuz-Atagunduz and Haluk Tarik Kani and Cafer Adiguzel and Tulin Firatli-Tuglular},
  booktitle={Oncology letters},
  year={2014}
}
BK-virus (BKV) is an important etiological agent for late-onset hemorrhagic cystitis (HC) in patients undergoing hematopoietic stem cell transplantation. Late-onset HC causes significant morbidity among these patients. Therapeutic approaches remain predominantly symptomatic. Several treatment options have been used with variable success rates. Cidofovir has the highest specificity against BKV; however, its lack of availability in the majority of countries, high costs and potential nephrotoxic… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
2 Extracted Citations
10 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 10 references

Similar Papers

Loading similar papers…